Enzymes that Unlock
Your Next Discovery
0
0
Resources
Company
Contact
X

Essential insights based on 3rd party publications:

Get the White Paper now
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X

Quantification Challenges of Chromatin — Associated Host Cell DNA:
An Underestimated Risk

  • Discover why host cell DNA quantities are often significantly underestimated.
  • Understand the limitation of conventional nucleases when degrading chromatin

Download the poster here
and get access to the
interactive Q&A

Get the Poster now
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X

The Largest Overlooked Cost Driver in Viral Vector Production

  • Up to half of produced vector is lost during Down Stream Processing(DSP)
  • The majority of manufacturing cost accumulates is DSP raw materials
  • Nuclease design decisions determine downstream economics

Download here and get access to the interactive Q&A

Get the Poster now
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Investors News

ArcticZymes Technologies ASA Capital Markets Day 2026 [Video]

Mar 6, 2026

Watch ArcticZymes’ management team outline the strategy to scale and diversify its enzyme platform across biomanufacturing and molecular tools.

Read More
Read More

ArcticZymes Releases New White Paper Quantifying the Impact of Optimized Nuclease Strategy on Viral Vector Manufacturing Economics

Feb 26, 2026

Explore how different nucleases can significantly impact viral vector manufacturing yield, downstream process complexity and product purity in this new white paper. This innovative model is based upon published data, provides researcher and bioprocess engineers with a new insight into how small changes can have significant impacts resulting in lower costs per dose.

Read More
Read More

ArcticZymes Technologies Reports Strong Q4 and FY 2025 Results: Accelerating Sales Growth and Improved Profitability

Feb 12, 2026

Tromsø, Norway, February 12, 2026 – ArcticZymes Technologies ASA (OSE: AZT) today reported financial results for the fourth quarter and full year 2025, reflecting accelerating sales growth, improved operating leverage and continued penetration in its core business segments. Following a return to growth in 2025, the Company enters 2026 with strengthened commercial momentum and a robust balance sheet.

Read More
Read More

ArcticZymes Technologies Reports Q3 2025 Results: Continued Growth Momentum and Strengthened Profitability

Nov 6, 2025

Tromsø, Norway, November 6, 2025 – ArcticZymes Technologies (OSE: AZT) today announced its financial results for the third quarter of 2025, reporting strong topline growth and solid operational performance.

Read More
Read More